BIOMAT Database Logo BIOMAT Database Logo

Synthesis, in vitro cytotoxicity and apoptosis inducing study of 2-aryl-3-nitro-2H-chromene derivatives as potent anti-breast cancer agents. 2014

Samira Rahmani-Nezhad, and Maliheh Safavi, and Mahboobeh Pordeli, and Sussan Kabudanian Ardestani, and Leila Khosravani, and Yaghoub Pourshojaei, and Mohammad Mahdavi, and Saeed Emami, and Alireza Foroumadi, and Abbas Shafiee
Department of Medicinal Chemistry, Faculty of Pharmacy and Drug Design & Development Research Center, Tehran University of Medical Sciences, Tehran, Iran.

A series of 2-aryl-3-nitro-2H-chromenes 4a-u were designed as hybrid analogs of flavanone, β-nitrostyrene and nitrovinylstilbene scaffolds. They were synthesized from the reaction of appropriate β-nitrostyrenes and salicylaldehydes in good yields. In vitro cytotoxic activities of compounds 4a-u were tested against breast cancer cell lines including MCF-7, T-47D and MDA-MB-231. Most compounds exhibited good cytotoxic activity against selected cell lines, being more potent than standard drug etoposide. Representatively, 8-methoxy-3-nitro-2-(4-chlorophenyl)-2H-chromene (4l) with IC50 = 0.2 μM against MCF-7 cells, was 36-times more potent than etoposide. Apoptosis as a mechanism of cell death for selected compounds 4h and 4l was confirmed morphologically by acridine orange/ethidium bromide double staining and TUNEL analysis, as well as caspase-3 activation assay.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002839 Chromans Benzopyrans saturated in the 2 and 3 positions. Dihydrobenzopyrans
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

Samira Rahmani-Nezhad, and Maliheh Safavi, and Mahboobeh Pordeli, and Sussan Kabudanian Ardestani, and Leila Khosravani, and Yaghoub Pourshojaei, and Mohammad Mahdavi, and Saeed Emami, and Alireza Foroumadi, and Abbas Shafiee
Concise synthesis and biological evaluation of 2-Aryl-3-Anilinobenzo[b]thiophene derivatives as potent apoptosis-inducing agents.
July 2021, Bioorganic chemistry,
Samira Rahmani-Nezhad, and Maliheh Safavi, and Mahboobeh Pordeli, and Sussan Kabudanian Ardestani, and Leila Khosravani, and Yaghoub Pourshojaei, and Mohammad Mahdavi, and Saeed Emami, and Alireza Foroumadi, and Abbas Shafiee
Synthesis of sulfonylhydrazone- and acylhydrazone-substituted 8-ethoxy-3-nitro-2H-chromenes as potent antiproliferative and apoptosis inducing agents.
August 2014, Archiv der Pharmazie,
Samira Rahmani-Nezhad, and Maliheh Safavi, and Mahboobeh Pordeli, and Sussan Kabudanian Ardestani, and Leila Khosravani, and Yaghoub Pourshojaei, and Mohammad Mahdavi, and Saeed Emami, and Alireza Foroumadi, and Abbas Shafiee
2-Ferrocenyl-3-nitro-2H-chromene.
January 2013, Acta crystallographica. Section E, Structure reports online,
Samira Rahmani-Nezhad, and Maliheh Safavi, and Mahboobeh Pordeli, and Sussan Kabudanian Ardestani, and Leila Khosravani, and Yaghoub Pourshojaei, and Mohammad Mahdavi, and Saeed Emami, and Alireza Foroumadi, and Abbas Shafiee
New 2-Imino-2H-Chromene-3(N-aryl)carboxamides as Potential Cytotoxic Agents.
January 2017, Anti-cancer agents in medicinal chemistry,
Samira Rahmani-Nezhad, and Maliheh Safavi, and Mahboobeh Pordeli, and Sussan Kabudanian Ardestani, and Leila Khosravani, and Yaghoub Pourshojaei, and Mohammad Mahdavi, and Saeed Emami, and Alireza Foroumadi, and Abbas Shafiee
Structure activity relationship of 3-nitro-2-(trifluoromethyl)-2H-chromene derivatives as P2Y6 receptor antagonists.
June 2021, Bioorganic & medicinal chemistry letters,
Samira Rahmani-Nezhad, and Maliheh Safavi, and Mahboobeh Pordeli, and Sussan Kabudanian Ardestani, and Leila Khosravani, and Yaghoub Pourshojaei, and Mohammad Mahdavi, and Saeed Emami, and Alireza Foroumadi, and Abbas Shafiee
Synthesis and biological evaluation of 3-aryl-quinolin derivatives as anti-breast cancer agents targeting ERα and VEGFR-2.
January 2019, European journal of medicinal chemistry,
Samira Rahmani-Nezhad, and Maliheh Safavi, and Mahboobeh Pordeli, and Sussan Kabudanian Ardestani, and Leila Khosravani, and Yaghoub Pourshojaei, and Mohammad Mahdavi, and Saeed Emami, and Alireza Foroumadi, and Abbas Shafiee
Imino-2H-Chromene Based Derivatives as Potential Anti-Alzheimer's Agents: Design, Synthesis, Biological Evaluation and in Silico Study.
January 2022, Chemistry & biodiversity,
Samira Rahmani-Nezhad, and Maliheh Safavi, and Mahboobeh Pordeli, and Sussan Kabudanian Ardestani, and Leila Khosravani, and Yaghoub Pourshojaei, and Mohammad Mahdavi, and Saeed Emami, and Alireza Foroumadi, and Abbas Shafiee
Synthesis, in vitro and in vivo evaluation of 2-aryl-4H-chromene and 3-aryl-1H-benzo[f]chromene derivatives as novel α-glucosidase inhibitors.
January 2019, Bioorganic & medicinal chemistry letters,
Samira Rahmani-Nezhad, and Maliheh Safavi, and Mahboobeh Pordeli, and Sussan Kabudanian Ardestani, and Leila Khosravani, and Yaghoub Pourshojaei, and Mohammad Mahdavi, and Saeed Emami, and Alireza Foroumadi, and Abbas Shafiee
6,8-Di-bromo-3-nitro-2-phenyl-2H-chromene.
June 2013, Acta crystallographica. Section E, Structure reports online,
Samira Rahmani-Nezhad, and Maliheh Safavi, and Mahboobeh Pordeli, and Sussan Kabudanian Ardestani, and Leila Khosravani, and Yaghoub Pourshojaei, and Mohammad Mahdavi, and Saeed Emami, and Alireza Foroumadi, and Abbas Shafiee
Design, synthesis, biological evaluation and molecular docking studies of novel 3-aryl-4-anilino-2H-chromen-2-one derivatives targeting ERα as anti-breast cancer agents.
June 2017, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!